Nephrotic syndrome after hematopoietic cell transplantation:: Do glomerular lesions represent renal graft-versus-host disease?

被引:113
作者
Brukamp, Kirsten
Doyle, Alden M.
Bloom, Roy D.
Bunin, Nancy
Tomaszewski, John E.
Cizman, Borut
机构
[1] Univ Penn, Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Div Oncol, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 1卷 / 04期
关键词
D O I
10.2215/CJN.00380705
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Glomerular disease associated with nephrotic syndrome has rarely been recognized as a distinct complication of allogeneic hematopoietic cell transplantation. Case reports in the English and Japanese literature since 1988 have described variable glomerular histology, comprising mainly membranous glomerulonephritis (MGN) in almost two thirds and minimal change disease (MCD) in nearly one quarter of patients. Review of the literature reveals a close temporal relationship between the development of nephrotic syndrome shortly after cessation of immunosuppression and the diagnosis of chronic graft-versus-host disease (GVHD). An association of glomerular disease with simultaneous GVHD was seen in 47% of patients overall. Nephrotic syndrome followed GVHD within 5 months in 60% of the combined MCD and MGN reports. A decrease in immunosuppressive medication use was linked to nephrotic syndrome occurrence within 9 months in 63% of patients with MCD and MGN. MCD occurred earlier after hematopoietic cell transplantation, was diagnosed sooner after medication change, and exhibited a better prognosis in comparison with MGN. Glomerular lesions after hematopoietic cell transplantation may therefore represent the renal manifestation of GVHD. Further studies are warranted to delineate the pathogenesis of this complication.
引用
收藏
页码:685 / 694
页数:10
相关论文
共 67 条
[1]  
Akar H, 2002, J NEPHROL, V15, P79
[2]   NEOPLASIA AND GLOMERULAR INJURY [J].
ALPERS, CE ;
COTRAN, RS .
KIDNEY INTERNATIONAL, 1986, 30 (04) :465-473
[3]  
Arat M, 2001, AM J KIDNEY DIS, V38, P218
[4]  
BARBARA JAJ, 1992, CLIN NEPHROL, V37, P115
[5]   Nephrotic syndrome in a bone marrow transplant recipient after cyclosporine withdrawal [J].
Bernis, C ;
Camara, R ;
Sánchez, AG ;
Martinez, MA ;
Selgas, R .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (11) :2457-2457
[6]  
BHUSHAN V, 2003, JAMA-J AM MED ASSOC, V19, P2599
[7]   IgA nephropathy complicating graft-versus-host disease, another nephropathy causing nephrotic syndrome after bone marrow transplantation [J].
Chan, GSW ;
Lam, MF ;
Au, WY ;
Tse, KC ;
Chan, TM ;
Lai, KN ;
Chan, KW .
HISTOPATHOLOGY, 2004, 45 (06) :648-651
[8]   Should we be performing more combined hematopoietic stem cell plus solid organ transplants? [J].
Chiang, KY ;
Lazarus, HM .
BONE MARROW TRANSPLANTATION, 2003, 31 (08) :633-642
[9]  
Chien YH, 2000, J FORMOS MED ASSOC, V99, P503
[10]   CLINICAL COURSE OF LATE-ONSET BONE-MARROW TRANSPLANT NEPHROPATHY [J].
COHEN, EP ;
LAWTON, CA ;
MOULDER, JE ;
BECKER, CG ;
ASH, RC .
NEPHRON, 1993, 64 (04) :626-635